参考文献/References:
[1] Hildreth CJ,Lynm C,Glass RM.Migraine headache[J]. JAMA,2009,301(24):2608.
[2] Rollnik JD,Tanneberger O,Schubert M,et al.Treatment of tension-type headache with botulinum toxin A:a double-blind,placebo-controlled study[J].Headache,2000,40(4):3000-3005.
[3] Diener HC,Dodick DW,Aurora SK,et al.OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial[J].Cephalalgia,2010,30(7):804-814.
[4] Chuang YC,Hsien K,Yoshimura N,et al.Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats[J].Journal of Urology,2004,171(4, S):94.
[5] Lucioni A,Bales GT,Lotan TL,et al.Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation[J].BJU Int,2008,101(3):366-370.
[6] Coelho A,Oliveira R,Cruz F,et al.Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats[J].Exp Neurol,2016,285(B):159-166.
[7] Ibragic S,Matak I,Dracic A,et al.Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats[J].Neurosci Lett,2016,617(617):213-217.
[8] Cui ML,Khanijou S,Rubino J,et al.Subcutaneous administration of botulinum toxin A reduces formalin-induced pain[J].Pain,2004,107(1/2):125-133.
[9] Da Silva L,Poulsen J,Arendt-Nielsen L,et al.Botulinum neurotoxin type A modulates vesicular release of glutamate from satellite glial cells[Z],2015:19.
[10] Gouin O,L'herondelle K,Lebonvallet N,et al.TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization[J].Protein Cell,2017,8(9):644-661.
[11] Matak I,Bolcskei K,Bach-Rojecky L,et al.Mechanisms of botulinum toxin type a action on pain[J].Toxins(Basel),2019,11(8):459.
[12] Wirkner K,Sperlagh B,Illes P.P2X(3)receptor involvement in pain states[J].Mol Neurobiol,2007,36(2):165-183.
[13] Drinovac V,Bach-Rojecky L,Lackovic Z.Association of antinociceptive action of botulinum toxin type A with GABA-A receptor[J].J Neural Transm,2014,121(6):665-669.
[14] Drinovac Vlah V,Bach-Rojecky L,Lackovi Z.Antinociceptive action of botulinum toxin type A in carrageenan-induced Mirror pain[J].J Neural Transm,2016,123(12):1403-1413.
[15] Perry CJ,Blake P,Buettner CA,et al.Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: implications for extracranial origin of headache[J].Ann Neurol,2016,79(6):1000-1013.
[16] Zychowska M,Rojewska E,Makuch WA,et al.Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain[J].Eur J Pharmacol,2016,791(791):377-388.